supply-chain disruption — e.g. “Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.” (Spain)
raw-material (API) supply problems — e.g. “Dificultades para obtener materia prima en el mercado” (Peru)
causes not stated by the regulator — e.g. “No se tiene más interés de continuar la comercialización del producto” (Peru)
manufacturing problems — e.g. “Modificaciones en el procedimiento de fabricación,Dificultades para obtener materia prima en el mercado” (Peru)
distribution issues — e.g. “Problemas de importación” (Peru)
Recent shortage history
Spain: resolved 4 Mar 2026 (began 28 Jan 2026)
Spain: resolved 24 May 2026 (began 22 Dec 2025)
Spain: resolved 9 Jul 2026 (began 9 Jul 2025)
Spain: resolved 4 Sept 2025 (began 26 May 2025)
Spain: resolved 23 Nov 2025 (began 19 Dec 2024)
Peru: resolved 3 Jul 2024 (began 3 Jul 2024)
Peru: resolved 11 Aug 2023 (began 11 Aug 2023)
Spain: resolved 23 Nov 2025 (began 6 Nov 2022)
Frequently asked questions
Is Ibuprofeno Kern Pharma currently in shortage?
Yes. As of the latest regulator updates, Ibuprofeno Kern Pharma has 26 active shortage notices across 2 countries (Spain, Peru). Status is refreshed daily from official regulatory sources.
Why is Ibuprofeno Kern Pharma in shortage?
Regulators attribute the current Ibuprofeno Kern Pharma shortages to supply-chain disruption, raw-material (API) supply problems, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Ibuprofeno Kern Pharma shortage be resolved?
Regulator-estimated resolution dates currently range from 31 Dec 2021 to 29 Dec 2029, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Ibuprofeno Kern Pharma shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Ibuprofeno Kern Pharma status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.